CNS Pharmaceutical
About:
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
Website: https://cnspharma.com/
Twitter/X: cns_pharma
Description:
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. CNS may also pursue the development of Berubicin to treat additional diseases, including pancreatic and ovarian cancers and lymphoma. CNS may also develop combination therapies that include Berubicin.
Total Funding Amount:
$25.9M
Headquarters Location:
Houston, Texas, United States
Founded Date:
2017-01-01
Founders:
John Climaco
Number of Employees:
1-10
Last Funding Date:
2024-10-23
IPO Status:
Public
Industries:
© 2025 bioDAO.ai